Cantel medical corp. (CMD)
CashFlow / Quarterly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11Jan'11Oct'10
Cash flows from operating activities
Net (loss) income

-2,263

5,767

8,825

8,175

18,800

19,242

16,888

18,736

32,488

22,929

16,997

17,511

18,070

18,800

16,291

14,019

15,389

14,254

13,273

12,356

11,085

11,239

10,705

10,249

11,126

11,185

10,213

8,998

10,452

9,576

9,649

8,174

7,294

6,220

4,682

5,048

5,720

4,975

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation

7,877

6,338

6,055

5,892

4,872

4,691

4,657

4,626

4,154

4,036

4,123

3,774

3,694

3,454

3,235

3,061

2,871

2,822

3,119

2,720

2,541

2,312

2,173

2,105

2,030

1,937

1,822

1,806

1,814

1,760

1,672

1,735

1,717

1,677

1,720

1,745

1,666

1,628

Amortization

8,974

6,029

5,341

4,956

4,511

6,041

4,465

4,480

4,364

4,048

6,477

3,964

4,057

3,909

3,358

3,346

3,297

3,094

3,617

3,460

3,232

2,956

2,759

2,637

2,619

2,626

2,623

2,598

2,573

2,267

2,278

2,279

2,278

2,289

1,497

1,465

1,406

1,319

Stock-based compensation expense

3,412

2,404

3,677

5,722

3,587

2,576

2,582

2,443

2,739

1,851

1,861

1,945

2,116

2,922

2,524

2,242

1,875

1,720

1,513

1,353

1,420

1,581

1,431

1,422

1,408

1,148

927

919

929

958

821

706

1,382

931

797

871

917

765

Amortization of right-of-use assets

3,223

2,722

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-3,921

1,454

609

425

-2,422

-674

-21

-1,046

-7,233

780

215

-918

-1,096

1,917

-1,613

-785

-634

1,322

-1,325

-800

-812

1,488

-1,220

-573

-416

991

-269

-238

-376

515

1,557

-316

-520

-351

-604

-314

-343

-538

Inventory step-up amortization

11,928

4,772

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

101

100

100

101

100

100

100

178

80

82

83

86

87

89

91

92

95

95

81

81

80

79

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-66

-11

-100

-151

-172

-24

-13

-199

-6

-171

-125

-60

16

-99

-41

-11

-58

-33

-3

-18

-1

-2

11

Fair value adjustments to contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20

21

-592

-69

-2,790

127

147

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-288

-333

-407

45

52

1,489

506

199

-10

2,473

576

518

701

2,596

889

118

955

913

655

653

444

218

285

259

212

20

Other non-cash items, net

-594

548

2,203

-417

1,390

-1,236

-490

-287

-366

67

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities, net of effects of acquisitions/dispositions:
Accounts receivable

-6,054

348

4,406

11,733

2,822

4,087

4,592

253

7,439

-8,584

-248

10,457

4,228

-1,577

2,414

7,294

2,785

236

-3,334

7,558

-3,269

2,950

-1,526

485

2,269

4,921

311

-129

1,477

788

1,705

373

2,229

-6,614

1,806

3,039

6,427

2,177

Inventories

-4,056

6,254

4,040

15,154

6,158

3,359

-6,006

1,718

5,444

2,629

-3,221

1,326

-816

1,824

1,877

9,430

1,956

2,295

2,768

4,192

1,726

1,389

578

268

603

1,209

949

4,309

-829

833

-731

668

384

1,906

982

894

1,530

-1,368

Prepaid expenses and other assets

833

-1,147

-2,565

1,949

4,069

-1,089

-2,087

5,117

-4,134

6,273

-1,967

-704

827

2,801

-2,187

3

-500

5,534

552

-1,378

3,039

783

1,035

128

-138

1,363

-62

-397

-227

2,073

-539

-542

-1,014

2,440

-481

-61

78

882

Accounts payable and other liabilities

-9,018

-13,664

-283

23,713

-11,160

1,055

-3,245

13,302

7,236

-6,679

-2,096

11,763

2,747

-5,290

3,139

16,199

1,324

-3,005

2,116

4,274

-5,650

-4,087

5,437

2,575

780

-2,587

4,779

4,918

-2,437

-6,329

3,514

859

3,725

-8,275

3,665

458

8,798

-5,655

Income taxes

-3,001

1,450

2,305

-1,172

-6,824

4,459

6,592

-408

-10,766

3,492

1,213

1,525

-5,544

1,911

2,888

2,036

-6,806

4,854

3,693

768

-4,446

4,549

2,681

1,702

-3,565

5,333

1,344

270

-2,084

5,100

-

-

-

3,057

1,406

930

-1,845

2,369

Operating lease liabilities

3,058

2,338

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

34,602

8,931

18,445

19,292

-3,075

32,269

35,909

35,332

24,599

30,072

34,809

28,383

20,093

24,908

28,465

23,532

13,156

15,115

25,696

14,536

6,135

12,703

23,545

19,178

10,798

10,751

17,003

15,440

9,681

9,370

17,727

13,015

12,142

7,696

10,670

6,154

8,154

3,220

Capital expenditures

10,708

10,390

20,051

13,325

23,228

38,834

13,926

10,296

6,984

6,492

6,300

6,349

6,273

8,143

6,631

4,623

4,468

3,167

4,431

3,057

2,217

3,055

5,655

3,523

2,181

2,182

2,711

1,486

1,378

1,170

1,642

1,311

1,259

1,290

1,140

1,408

2,095

1,192

Proceeds from disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

4

17

5

21

-

-

-

-

-24

15

19

15

6

5

0

3

-

-

-

-

-

-

-

-

33

0

16

29

Acquisition of Sterilator, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-639

95,900

-

-

-

-

Acquisitions, net of cash acquired

27,418

658,932

0

16,597

7,047

17,000

2,893

20,308

3,942

60,345

46

11,650

580

57,768

-96

13,520

1,294

79,810

-

-

-

-

-

-

-

-

-

-

-

-

0

517

516

517

520

514

516

20,600

Restricted cash for IMS Acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24,257

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net asset value adjustment for PuriCore Acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-337

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

-

-

-

-

-

-

-

-

-

-

-

-283

194

-255

-428

301

-224

12

95

410

-802

56

-146

185

23

296

127

41

24

70

-242

184

-39

53

87

47

82

98

Net cash used in investing activities

-35,890

-669,322

-20,051

-29,922

-27,222

-55,834

-16,819

-30,604

-10,926

-66,837

-6,686

-17,699

-7,042

-65,635

-6,066

-18,424

-5,503

-82,989

-4,661

-9,782

-10,835

-27,016

-30,889

-3,703

-10,365

-2,475

-2,838

-9,799

-38,169

-1,240

-1,391

-2,867

-1,097

-97,760

-1,714

-9,469

-2,677

-21,861

Borrowings of long-term debt

0

400,000

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-2

49,649

-

-

-

-

Repayments of long-term debt

2,375

2,375

2,500

7,707

2,500

2,500

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings under revolving credit facility

26,500

291,400

0

5,000

45,000

0

0

21,000

0

61,300

0

13,000

0

61,000

0

13,500

0

83,000

0

10,000

12,000

25,000

-

-

-

-

-

-

-

-

0

0

-5

46,946

0

7,500

0

20,500

Repayments under term loan facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

Repayments under revolving credit facility

10,000

10,900

0

7,000

0

0

169,000

12,000

8,000

19,300

19,000

17,000

12,000

16,000

16,000

15,000

14,000

14,000

13,000

14,000

10,000

12,000

12,000

10,000

5,000

10,500

7,500

7,500

7,500

7,500

8,000

5,000

6,000

3,000

3,500

2,500

3,000

6,000

Proceeds from exercises of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

215

70

0

323

224

203

93

114

244

164

1,236

173

421

775

786

390

556

655

1,263

81

Debt issuance costs

0

9,234

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease liabilities

82

127

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-407

45

52

1,489

506

199

-10

2,473

576

518

701

2,596

889

118

955

913

655

653

444

218

285

259

212

20

Purchases of treasury stock

87

3,613

113

273

67

4,288

858

264

130

5,822

523

123

48

6,216

181

119

294

3,138

191

112

150

3,274

245

137

438

3,619

353

27

294

1,578

402

779

430

293

384

425

414

67

Net cash provided by financing activities

9,485

665,151

-6,790

-9,980

38,260

-6,788

23,899

8,735

-11,675

36,178

-22,443

-4,123

-14,969

38,784

-19,091

-1,574

-16,744

67,351

-14,548

-3,843

-236

12,522

14,692

-10,730

-9,002

-13,909

-10,742

-1,745

27,403

-10,492

-11,091

-6,851

-8,965

91,410

-6,578

2,989

-5,468

12,034

Effect of exchange rate changes on cash and cash equivalents

1,248

-10

1,583

927

-962

286

-808

-1,524

759

1,223

31

-39

134

-289

-439

360

-436

-66

-132

362

-686

-276

-41

23

-178

10

-16

-52

44

42

-86

41

-37

-110

-7

290

112

-51

Increase (decrease) in cash and cash equivalents

9,445

4,750

-6,813

-19,683

7,001

-30,067

42,181

11,939

2,757

636

5,711

6,522

-1,784

-2,232

2,869

3,894

-9,527

-589

6,355

1,273

-5,622

-2,067

7,307

4,768

-8,747

-5,623

3,407

3,844

-1,041

-2,320

5,159

3,338

2,043

1,236

2,371

-36

121

-6,658